|
|
Explore our excellent programs for needs-based learning to sharpen your clinical skills and improve patient outcomes in a variety of therapeutic areas. Our triple accreditation (for physicians, nurses, and pharmacists) results in reliably high-quality programs, many with a multidisciplinary team approach. Learning preferences are met with a full range of educational formats: online case-based activities, virtual lectures, downloadable print, live meetings and symposia.
|
Based on live presentations from the AMCP Annual Meeting, the dual-track virtual lectures are designed to educate managed care professionals to adapt their current approaches and roles as providers in order to implement new treatment regimens that emphasize a more convenient and patient-centered approach for anticoagulation therapy. Supported by an educational grant from Boehringer Ingelheim.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
The Food and Drug Administration Amendments Act of 2007 (FDAAA) authorizes the Food and Drug Administration (FDA) to require pharmaceutical manufacturers to submit a Risk Evaluation and Mitigation Strategy (REMS) if safety data suggest that a REMS is necessary to ensure that the benefits of the drug outweigh the potential risks. The FDA may require a REMS prior to product approval or post-approval for products that did not initially require a REMS. A REMS may include such strategies for managing risks associated with potentially harmful drugs as medication guides, communication plans for health care professionals, and elements to assure safe use (ETASU). The purpose of this activity is to improve the overall knowledge of, competency with, and performance for the administration of a REMS in a managed care setting. Current and evolving pain management REMS appropriate for a managed care setting will be utilized as a best practice model for a successful approach to meeting REMS requirements. Supported by an educational grant from Purdue.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
During the last two decades, managed care organizations (MCOs) have spent a considerable amount of time and resources managing prescription drug costs for large chronic disease categories. Because managed care leaders have identified oncology drugs and biologics as priority areas for managing costs, education is needed to obtain the knowledge to develop and implement new strategies, coordinate oncology care through case management, educate patients about treatment with current and emerging cancer drugs, and collaborate effectively with specialty pharmacy management. Utilizing the management of multiple myeloma as an example, this activity will recommend emerging oncology pharmacy management strategies and methods for managed care professionals to implement within their current setting as well as extrapolate to other types of cancer as needed. Supported by an educational grant from Celgene Corporation.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
WEBCAST ARCHIVES NOW AVAILABLE! Based on the live webcast series, these CME/CNE/CPE webcast archives explore how to optimize outcomes for patients with growth hormone deficiency and other growth disorders. Despite the often severe physical and psychosocial effects of growth hormone disorders on health plan members, the significance and impact of these conditions are often underestimated or overlooked. Participants will receive a complimentary “Tool Box” to help optimize patient outcomes for growth/growth hormone disorders. Supported by an educational grant from Novo Nordisk, Inc.
Track 1: Recommendations for Medical Directors, Pharmacy Directors, and Quality Directors
Track 2: Recommendations for Care Managers
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
[Back To The Top]
|
Video lecture with Marilyn Haas, PhD, CNS, ANP-BC, which includes an overview of the principles of radiation therapy, the variety of radiation treatment modalities and clinical applications of each. This activity is designed for oncology nurses and other health care providers interested in the care of oncology patients. Supported by OncUView.tv.
This online module is accredited by Meniscus Educational Institute and is hosted by OncUView.tv®. Visit and register at Oncuview.tv to access this activity.
Accreditation extended to November 30, 2012.
[go to this CE Offering]
During the last two decades, managed care organizations (MCOs) have spent a considerable amount of time and resources managing prescription drug costs for large chronic disease categories. Because managed care leaders have identified oncology drugs and biologics as priority areas for managing costs, education is needed to obtain the knowledge to develop and implement new strategies, coordinate oncology care through case management, educate patients about treatment with current and emerging cancer drugs, and collaborate effectively with specialty pharmacy management. Utilizing the management of multiple myeloma as an example, this activity will recommend emerging oncology pharmacy management strategies and methods for managed care professionals to implement within their current setting as well as extrapolate to other types of cancer as needed. Supported by an educational grant from Celgene Corporation.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
Sign up today! A lecture series for nurses involved in the management of patients with MDS. Sign up today to request a lecture for you and your colleagues. Supported by an educational grant from Celgene Corporation.
[go to this CE Offering]
Sign up today! A lecture series for nurses involved in the management of patients with MM. Sign up today to request a lecture for you and your colleagues. Supported by an educational grant from Celgene Corporation.
[go to this CE Offering]
WEBCAST ARCHIVES NOW AVAILABLE! Based on the live webcast series, these CME/CNE/CPE webcast archives explore how to optimize outcomes for patients with growth hormone deficiency and other growth disorders. Despite the often severe physical and psychosocial effects of growth hormone disorders on health plan members, the significance and impact of these conditions are often underestimated or overlooked. Participants will receive a complimentary “Tool Box” to help optimize patient outcomes for growth/growth hormone disorders. Supported by an educational grant from Novo Nordisk, Inc.
Track 1: Recommendations for Medical Directors, Pharmacy Directors, and Quality Directors
Track 2: Recommendations for Care Managers
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
Case Studies Now Available
The overall purpose of this educational activity is to present the knowledge nurses need to better understand the importance of managing BTCP, and to provide potential strategies for application to their clinical practices. This activity will help reduce barriers that prevent the integration of therapies into practice and will support adherence to current guidelines. Supported by an educational grant from Cephalon, Inc.
[go to this CE Offering]
A journal supplement with select presentation ummaries from the Sixth Annual Chicago Supportive Oncology Conference held October 7-9, 2010. This continuing education activity is designed for physicians, nurses, nurse practitioners, physician assistants, residents, and fellows who will gain important insights about practical management issues in the palliative and supportive care of patients with neoplastic diseases.
[go to this CE Offering]
An e-newsletter that focuses on symptom management including recent updates for multiple myeloma (MM) and chronic lymphocytic leukemia (CLL), covering peripheral neuropathy, thromboembolic events, and renal complications of treatment. This activity is intended for oncology nurses and nurse practitioners, as well as other health care professionals interested in the care of elderly patients with MM and CLL. Supported by an educational grant from Celgene Corporation.
[go to this CE Offering]
An e-newsletter that focuses on symptom management and treatment updates for non-Hodgkin (NHL) and Hodgkin lymphomas (HL) and discusses fatigue, infectious complications, and hypersensitivity in these patients. This activity is intended for oncology nurses and nurse practitioners, as well as other health care professionals interested in the care of elderly patients with NHL and HL. Supported by an educational grant from Celgene Corporation.
[go to this CE Offering]
An e-newsletter that reviews recent advances in the diagnosis, prognostication, risk-adapted treatment selection, and management of adverse events in patients with MDS, with consideration of the unique needs of the older patient. Supported by an educational grant from Celgene Corporation.
[go to this CE Offering]
In the United States, colorectal cancer (CRC) is the third most common cause of new cancer cases and cancer-related deaths in men and women. This educational activity provides an update on the current status of CRC, including epidemiology, early detection, and survival trends. The current treatment regimens for management of CRC in the adjuvant and metastatic settings are discussed, as well as nursing implications for managing toxicities of these regimens. The overall purpose is to provide oncology nurses with information on state-of-the-art treatment and side effect management for CRC to assist them in educating, supporting, and caring for patients with this disease.
This online video lecture is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
[go to this CE Offering]
Evidence-based clinical practice is an approach to decision-making in which the clinician uses the best evidence available, in consultation with the patient, to decide on the option that best suits that patient. Evidence-based practice (EBP) is a way for health care providers to examine nursing practices, analyze alternative and contradictory data, and make sound decisions supported by the best available research evidence. This systematic approach increases the likelihood that patients will receive the best care possible.
This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
[go to this CE Offering]
Changes in treatment of solid tumors over the past decade have led to new side effects not often seen with treatments in the past. Over a decade ago, capecitabine, an oral fluoropyrimidine prodrug, was introduced. More recently, epidermal growth factor receptor inhibitors (EGFRIs) and multikinase inhibitors (MKIs) have become standard of care in treating certain solid tumors. These new drugs have introduced a variety of dermatologic side effects and nurses need to be prepared to educate and treat patients experiencing these side effects. This CE module for oncology nurses will address dermatologic side effects commonly associated with cancer therapy.
This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
[go to this CE Offering]
This module will provide oncology nurses with the information they need to better educate their patients and the public on the importance of screening for CRC and the methods that are most appropriate. This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
[go to this CE Offering]
Clinical Biostatistics: Part 2— Understanding statistics is important to the care of patients with cancer because appropriate treatment choice is primarily based on data about its safety and effectiveness generated from clinical trials or other studies. The goal of this activity is to discuss levels of measurement, data types, statistical significance and the different ways data can be displayed and their clinical significance. This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
Accreditation extended to December 31, 2012.
[go to this CE Offering]
Clinical Biostatistics: Part 3—This module discusses the most common methods of statistical analysis used in medical and nursing research. The overall objective is to help nurses make critical decisions about the validity of research studies that may be applicable to clinical practice. This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
Accreditation extended to December 31, 2012.
[go to this CE Offering]
Clinical Biostatistics: Part 4—A meta-analysis is a statistical analysis that collates data from different clinical trials to elicit a single conclusion about outcomes. The goal of this module is to define the steps in conducting a meta-analysis with examples and how the results of a meta-analysis can be used in practice. This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
Accreditation extended to December 31, 2012.
[go to this CE Offering]
By 2030, statisticians estimate that 20% of the United States population will be 65 years of age or older. The relationship between aging and cancer risk is complex and far from understood. The median age at diagnosis is 68 years. Questions about cancer management in the elderly remain unanswered due to our lack of understanding of the influence of age on tumor biology. Advancing age alone should not preclude the use of effective cancer treatment although the elderly are under represented in clinical trials. The elderly population utilizes a significant portion of the U.S. federal health budget. The associated burden of care extends to the medical community assuming care of this growing population. This activity will offer oncology nurses specific issues related to the management of cancer in older individuals that include application to current standards of care.
This online module is located under Continuing Education on ManageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
Accreditation extended to November 30, 2012.
[go to this CE Offering]
Learn more about managing Sleep Disorders in patients with cancer. This online module is located in Symptom Management on manageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
Accreditation extended to April 2012
[go to this CE Offering]
Approximately 15% of patients with cancer will develop a VTE. Those without cancer, a diagnosis of thrombosis may predict a pending malignancy. These important facts and how to manage a VTE are available on manageCRC.com, a Web site supported by an educational grant from Lilly USA, LLC.
Accreditation extended to April 2012
[go to this CE Offering]
Clinical Biostatistics, a new section on manageCRC, opens with an easy-to-understand module on information and application of clinical trials for the clinician. The Web site is supported by an educational grant from Lilly USA, LLC.
Accreditation extended to April 2012
[go to this CE Offering]
[Back To The Top]
|
Based on live presentations from the AMCP Annual Meeting, the dual-track virtual lectures are designed to educate managed care professionals to adapt their current approaches and roles as providers in order to implement new treatment regimens that emphasize a more convenient and patient-centered approach for anticoagulation therapy. Supported by an educational grant from Boehringer Ingelheim.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
The Food and Drug Administration Amendments Act of 2007 (FDAAA) authorizes the Food and Drug Administration (FDA) to require pharmaceutical manufacturers to submit a Risk Evaluation and Mitigation Strategy (REMS) if safety data suggest that a REMS is necessary to ensure that the benefits of the drug outweigh the potential risks. The FDA may require a REMS prior to product approval or post-approval for products that did not initially require a REMS. A REMS may include such strategies for managing risks associated with potentially harmful drugs as medication guides, communication plans for health care professionals, and elements to assure safe use (ETASU). The purpose of this activity is to improve the overall knowledge of, competency with, and performance for the administration of a REMS in a managed care setting. Current and evolving pain management REMS appropriate for a managed care setting will be utilized as a best practice model for a successful approach to meeting REMS requirements.
Supported by an educational grant from Purdue.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
During the last two decades, managed care organizations (MCOs) have spent a considerable amount of time and resources managing prescription drug costs for large chronic disease categories. Because managed care leaders have identified oncology drugs and biologics as priority areas for managing costs, education is needed to obtain the knowledge to develop and implement new strategies, coordinate oncology care through case management, educate patients about treatment with current and emerging cancer drugs, and collaborate effectively with specialty pharmacy management. Utilizing the management of multiple myeloma as an example, this activity will recommend emerging oncology pharmacy management strategies and methods for managed care professionals to implement within their current setting as well as extrapolate to other types of cancer as needed.
Supported by an educational grant from Celgene Corporation.
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
WEBCAST ARCHIVES NOW AVAILABLE! Based on the live webcast series, these CME/CNE/CPE webcast archives explore how to optimize outcomes for patients with growth hormone deficiency and other growth disorders. Despite the often severe physical and psychosocial effects of growth hormone disorders on health plan members, the significance and impact of these conditions are often underestimated or overlooked. Participants will receive a complimentary “Tool Box” to help optimize patient outcomes for growth/growth hormone disorders. Supported by an educational grant from Novo Nordisk, Inc.
Track 1: Recommendations for Medical Directors, Pharmacy Directors, and Quality Directors
Track 2: Recommendations for Care Managers
This activity is coprovided and hosted by Impact Education. Visit and register at www.impactedu.net to access this activity.
[go to this CE Offering]
[Back To The Top]
|
|
